Position in EWTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,800,310
+$7,662,801 QoQ
Shares Held
342,867
+171.2% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Derivatives in EWTX
reported options exposure · as of Dec 31, 2025CallValue
$744,450
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in EWTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,800,310 | 342,867 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,137,509 | 126,436 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $744,450 | 30,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $11,766,393 | 725,425 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,086,961 | 921,965 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,532,596 | 615,118 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,456,400 | 66,200 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $267,000 | 10,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $23,735,445 | 888,968 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $533,800 | 20,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $1,868,300 | 70,000 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $26,343,830 | 987,030 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,630,563 | 1,145,506 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,708,331 | 532,255 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,437,023 | 131,355 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $205,666 | 35,893 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $377,339 | 42,208 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,559,580 | 158,494 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $535,755 | 67,306 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $591,622 | 60,992 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $1,952,502 | 60,077 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||